Reduced-dose post-transplant cyclophosphamide plus low-dose post-transplant anti-thymocyte globulin as graft-versus-host disease prophylaxis with fludarabine-busulfan-cytarabine conditioning in haploidentical peripheral blood stem cell transplantation: A multicentre, randomized controlled clinical trial.

Zhang, Wenli; Gui, Ruirui; Zu, Yingling; Zhang, Binglei; Li, Zhen; Zhang, Yanli; Wang, Xianjing; Guo, Shuli; Zhan, Xinrong; Fu, Yuewen; Song, Yongping; Zhou, Jian

Zhang, Wenli; Gui, Ruirui; Zu, Yingling; Zhang, Binglei; Li, Zhen; Zhang, Yanli; Wang, Xianjing; Guo, Shuli; Zhan, Xinrong; Fu, Yuewen; Song, Yongping; Zhou, Jian.

Afiliação

Zhang W; Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China.
Gui R; Academy of Medical Sciences, Zhengzhou University, Zhengzhou, China.
Zu Y; Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China.
Zhang B; Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China.
Li Z; Academy of Medical Sciences, Zhengzhou University, Zhengzhou, China.
Zhang Y; Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China.
Wang X; Academy of Medical Sciences, Zhengzhou University, Zhengzhou, China.
Guo S; Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China.
Zhan X; Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China.
Fu Y; Department of Hematology, The Third People's Hospital of Zhengzhou, Zhengzhou, China.
Song Y; Department of Hematology, Luoyang Central Hospital Affiliated to Zhengzhou University, Luoyang, China.
Zhou J; Department of Hematology, Xinxiang Central Hospital, Xinxiang, China.

Br J Haematol ; 200(2): 210-221, 2023 01.

Article em En | MEDLINE | ID: mdl-36200642

Assuntos

Doença Enxerto-Hospedeiro; Transplante de Células-Tronco Hematopoéticas; Transplante de Células-Tronco de Sangue Periférico; Humanos; Soro Antilinfocitário/uso terapêutico; Bussulfano/uso terapêutico; Citarabina/uso terapêutico; Recidiva Local de Neoplasia/tratamento farmacológico; Ciclofosfamida/uso terapêutico; Transplante de Células-Tronco Hematopoéticas/efeitos adversos; Transplante de Células-Tronco Hematopoéticas/métodos; Doença Enxerto-Hospedeiro/etiologia; Doença Enxerto-Hospedeiro/prevenção & controle; Doença Enxerto-Hospedeiro/tratamento farmacológico; Condicionamento Pré-Transplante/métodos; Estudos Retrospectivos

Palavras-chave

anti-thymocyte globulin; graft-versus-host disease; haematopoietic stem cell transplantation; haploidentical; post-transplant cyclophosphamide

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Transplante de Células-Tronco de Sangue Periférico / Doença Enxerto-Hospedeiro Tipo de estudo: Clinical_trials / Guideline Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google